Physician profile
Ghulam Awan
NPI 1760431662
$9,322.87
in general payments reported to CMS, 2019-2025
22 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,340 · 2020: $722 · 2021: $2,056 · 2022: $134 · 2023: $3,612 · 2024: $269 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,400 · Food and Beverage: $1,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,399.56 |
| Food and Beverage | $1,672.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,293.14 | 2019-2025 | Supera, Diamondback Peripheral, Esprit |
| Medtronic, INC. | $3,948.61 | 2021-2023 | Venaseal, Micra |
| Boston Scientific Corporation | $465.79 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Amgen INC. | $67.72 | 2019-2022 | |
| Philips North America LLC | $65.47 | 2024 | (Ck4) Mcot, (Bs0) Mechanical Atherectomy |
| Cardiovascular Systems INC. | $57.67 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $48.00 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $43.41 | 2022-2023 | Lutonix Drug Coated Balloon |
| Janssen Pharmaceuticals, INC | $41.97 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $39.22 | 2019-2022 | |
| Route 92 Medical, INC. | $36.60 | 2023 | 8f Base Camp Sheath System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.06 | 2021-2022 | |
| Gilead Sciences, INC. | $24.54 | 2019 | |
| Pfizer INC. | $24.04 | 2019 | |
| Z-Medica, LLC | $23.18 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $22.85 | 2024 | Impella |
| Medtronic Vascular, INC. | $19.49 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.97 | 2023 | |
| Lantheus Medical Imaging, INC. | $14.95 | 2020 | |
| Terumo Medical Corporation | $11.84 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.26 | 2019 | |
| Ge Healthcare | $8.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghulam Awan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.